MedTrace Logo

SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement

NCT01482325 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2016-09-30

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to show that the noninvasive blood pressure software algorithm meets engineering requirements.

Conditions

  • Blood Pressure (Low, Normal, High)

Interventions

DEVICE

Blood pressure monitoring with GE Healthcare DASH2500 Patient Monitor

10-20 Non-Invasive Blood Pressure readings on investigational software in the DASH2500 Patient Monitor

Sponsors & Collaborators

  • GE Healthcare

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01482325 on ClinicalTrials.gov